Understanding the needs of women considering risk-reducing salpingo-oophorectomy
- PMID: 22964868
- PMCID: PMC3637391
- DOI: 10.1097/NCC.0b013e3182642cb5
Understanding the needs of women considering risk-reducing salpingo-oophorectomy
Abstract
Background: Because of the significantly increased lifetime risk of ovarian cancer associated with inheritance of a germline mutation in the BRCA1/2 genes, women with a deleterious mutation are recommended to undergo risk-reducing salpingo-oophorectomy at age 35 years or once child-bearing is complete. Significant time is often spent by nurses trained in genetics providing counseling to improve the decision-making process. The decision to undergo surgery is complex and laden with several sources of uncertainty.
Objective: We conducted a qualitative study among female carriers of deleterious BRCA1/2 mutations to address these uncertainties.
Methods: Twelve qualitative interviews were conducted with women who had received a positive BRCA1/2 test result to explore their understanding of ovarian cancer risk, prevention options, and resource needs. Qualitative content analysis was performed.
Results: Significant information gaps in level of risk, other factors associated with ovarian cancer, and details of prophylactic oophorectomy were identified. Personal experience with cancer colored the degree of risk perception associated with the inherited mutation. Fear of the adverse effects of surgical menopause, both physiological and psychosocial, was common. Women expressed interest in hearing from other women facing the same decision.
Conclusions: Women facing the decision to undergo risk-reducing salpingo-oophorectomy have several information gaps and unmet needs despite comprehensive counseling.
Implications for practice: Based on our findings, we make specific recommendations that will guide nursing practice and future research.
Conflict of interest statement
Conflicts of Interest
The authors have no conflicts of interest to disclose.
Similar articles
-
Surgical decision making in premenopausal BRCA carriers considering risk-reducing early salpingectomy or salpingo-oophorectomy: a qualitative study.J Med Genet. 2022 Feb;59(2):122-132. doi: 10.1136/jmedgenet-2020-107501. Epub 2021 Feb 10. J Med Genet. 2022. PMID: 33568437 Free PMC article.
-
Salpingectomy With Delayed Oophorectomy in BRCA1/2 Mutation Carriers: Estimating Ovarian Cancer Risk.Obstet Gynecol. 2016 Jun;127(6):1054-1063. doi: 10.1097/AOG.0000000000001448. Obstet Gynecol. 2016. PMID: 27159752
-
Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy.Am J Obstet Gynecol. 2006 Jun;194(6):1702-9. doi: 10.1016/j.ajog.2006.03.006. Am J Obstet Gynecol. 2006. PMID: 16731090
-
Prophylactic and risk-reducing bilateral salpingo-oophorectomy: recommendations based on risk of ovarian cancer.Obstet Gynecol. 2010 Sep;116(3):733-743. doi: 10.1097/AOG.0b013e3181ec5fc1. Obstet Gynecol. 2010. PMID: 20733460 Review.
-
Prophylactic oophorectomy in women at increased cancer risk.Curr Opin Obstet Gynecol. 2007 Feb;19(1):27-30. doi: 10.1097/GCO.0b013e32801195da. Curr Opin Obstet Gynecol. 2007. PMID: 17218848 Review.
Cited by
-
Factors associated with the decision to undergo risk-reducing salpingo-oophorectomy among women at high risk for hereditary breast and ovarian cancer: a systematic review.Korean J Women Health Nurs. 2020 Dec 31;26(4):285-299. doi: 10.4069/kjwhn.2020.11.19. Epub 2020 Dec 9. Korean J Women Health Nurs. 2020. PMID: 36312308 Free PMC article. Review.
-
The Psychosocial Impact of the Decision to Undergo Risk-Reducing Salpingo-Oophorectomy Surgery in BRCA Mutation Carriers and the Role of Physician-Patient Communication.Curr Oncol. 2023 Feb 17;30(2):2429-2440. doi: 10.3390/curroncol30020185. Curr Oncol. 2023. PMID: 36826146 Free PMC article. Review.
-
Advances in tumor screening, imaging, and avatar technologies for high-grade serous ovarian cancer.Front Oncol. 2014 Nov 18;4:322. doi: 10.3389/fonc.2014.00322. eCollection 2014. Front Oncol. 2014. PMID: 25478323 Free PMC article. Review.
-
Patient perspectives on risk-reducing salpingectomy with delayed oophorectomy for ovarian cancer risk-reduction: A systematic review of the literature.Gynecol Oncol. 2023 Jun;173:106-113. doi: 10.1016/j.ygyno.2023.04.006. Epub 2023 Apr 26. Gynecol Oncol. 2023. PMID: 37116391 Free PMC article.
-
The needs of Southeast Asian BRCA mutation carriers considering risk-reducing salpingo-oophorectomy: a qualitative study.Fam Cancer. 2022 Jan;21(1):21-33. doi: 10.1007/s10689-021-00232-6. Epub 2021 Feb 19. Fam Cancer. 2022. PMID: 33604745
References
-
- Daly MB, Axilbund JE, Buys S, et al. Genetic/Familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw. 2010;8(5):562–594. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous